Search - tctmd.com

Displaying 761 - 780 of 13289

Sort: Relevancy | Date

Presentation TCT 2024

TCT 369: Functional Hemodynamic Assessment of a Novel Endoluminal Fibrillated Polymeric Scaffold up to Full Resorption Within 12 Months in a Preclinical In-Vivo Setting

Presenter: KOTARO MIYASHITA

October 29, 2024

Presentation TCT 2024

A Novel Transcatheter Technique to Repair the Tricuspid Valve (StarTric): Technology Description and Experimental Insights

Presenter: Daniele Zanotti

October 29, 2024

Presentation TCT 2024

TCT 1340: Case Report: Does Commissural Misalignment Result in Early Degeneration of Transcatheter Valve and Affect Its Function?

Presenter: Noah Dessalegn

October 29, 2024

Presentation TCT 2024

TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy

Presenter: Nancy Virginia

October 29, 2024

Presentation TCT 2024

TCT 455: Quantitative Coronary Dissection Volume After Sirolimus or Paclitaxel Coated Balloon and Lumen Changes at 6 Months: Serial OCT Sub-study of TRANSFORM-I Trial

Presenter: Akihiro Tobe

October 29, 2024

Presentation TCT 2024

TCT 451: Plaque Changes and Vessel Remodeling After Balloon Angioplasty for De Novo Coronary Lesions Using Paclitaxel-Coated Balloons: A Serial IB-IVUS Study

Presenter: Shelby Kerr

October 29, 2024

Presentation TCT 2024

TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures

Presenter: Simon Eccleshall

October 29, 2024

Presentation TCT 2024

TCT 454: Procedural Predictors of Optimal Angiographic Lesion Outcomes After Drug-Coated Balloon Treatment for De Novo Coronary Artery Disease

Presenter: Dong Oh Kang

October 29, 2024

Presentation TCT 2024

TCT 453: Comparison of “Predicted” Versus “Calculated” Flow Ratio (µFR) Acquired With Single-Angiografic View to Guide Drug-Coated Balloon Angioplasty in Coronary De-Novo Lesions

Presenter: Stefano Galli

October 29, 2024

Presentation TCT 2024

TCT 452: Angio-Based Quantitative Fractional Ratio After Drug-Coated Balloon for De Novo Coronary Lesions: Potential Role of Single View-Based Analysis

Presenter: Stefano Galli

October 29, 2024

News Conference News TCT 2024

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Caitlin E. Cox

October 28, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

Presentation TCT 2024

The DurAVR System with Biomimetic Leaflet Design: Impact on Flow Dynamics and LV Mass Regression

Presenter: Amar Krishnaswamy

October 28, 2024

Presentation TCT 2024

The Ballon Expandable Siegel TAVR System: A Low-Profile Molybdenum-Rhenium Alloy Frame Design (MIRus)

Presenter: Pradeep Yadav

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

TCT 590: Mitigating Myocardial Reperfusion Injury in Coronary Revascularization: The Role of Protein Kinase C Epsilon Peptide Inhibitor

Presenter: Desmond Boakye Tanoh

October 28, 2024

Presentation TCT 2024

TCT 1296: Yet Another Ventricular Septal Defect and Free Wall Rupture Despite Early Revascularization?: What Have We Learned, and When Will We Find a Solution?

Presenter: Laura Muller

October 28, 2024

Presentation TCT 2024

What Does an Interventional Cardiologist Need to Know about Contemporary Trancatheter and Surgical Aortic Intervention

Presenter: Nimesh Desai

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Advertisement

TCT 369: Functional Hemodynamic Assessment of a Novel Endoluminal Fibrillated Polymeric Scaffold up to Full Resorption Within 12 Months in a Preclinical In-Vivo Setting

A Novel Transcatheter Technique to Repair the Tricuspid Valve (StarTric): Technology Description and Experimental Insights

TCT 1340: Case Report: Does Commissural Misalignment Result in Early Degeneration of Transcatheter Valve and Affect Its Function?

TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy

TCT 455: Quantitative Coronary Dissection Volume After Sirolimus or Paclitaxel Coated Balloon and Lumen Changes at 6 Months: Serial OCT Sub-study of TRANSFORM-I Trial

TCT 451: Plaque Changes and Vessel Remodeling After Balloon Angioplasty for De Novo Coronary Lesions Using Paclitaxel-Coated Balloons: A Serial IB-IVUS Study

TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures

TCT 454: Procedural Predictors of Optimal Angiographic Lesion Outcomes After Drug-Coated Balloon Treatment for De Novo Coronary Artery Disease

TCT 453: Comparison of “Predicted” Versus “Calculated” Flow Ratio (µFR) Acquired With Single-Angiografic View to Guide Drug-Coated Balloon Angioplasty in Coronary De-Novo Lesions

TCT 452: Angio-Based Quantitative Fractional Ratio After Drug-Coated Balloon for De Novo Coronary Lesions: Potential Role of Single View-Based Analysis

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

The DurAVR System with Biomimetic Leaflet Design: Impact on Flow Dynamics and LV Mass Regression

The Ballon Expandable Siegel TAVR System: A Low-Profile Molybdenum-Rhenium Alloy Frame Design (MIRus)

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

TCT 590: Mitigating Myocardial Reperfusion Injury in Coronary Revascularization: The Role of Protein Kinase C Epsilon Peptide Inhibitor

TCT 1296: Yet Another Ventricular Septal Defect and Free Wall Rupture Despite Early Revascularization?: What Have We Learned, and When Will We Find a Solution?

What Does an Interventional Cardiologist Need to Know about Contemporary Trancatheter and Surgical Aortic Intervention

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content